Clinical trial
6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer
NCT00189644 · Association Européenne de Recherche en Oncologie, Other · Unknown status
Key facts
| NCT number | NCT00189644 |
|---|---|
| Title | 6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer |
| Lead sponsor | Association Européenne de Recherche en Oncologie, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | 6 FEC 100, 4 FEC 100 followed by 4 Taxol |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 19, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: